tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Jacobio’s KRAS G12C and SHP2 Therapy Shows Promising Results in Clinical Trials
PremiumCompany AnnouncementsJacobio’s KRAS G12C and SHP2 Therapy Shows Promising Results in Clinical Trials
3M ago
Jacobio Pharmaceuticals Appoints Dr. Andrea Wang-Gillam as Co-CEO to Boost Global Strategy
Premium
Company Announcements
Jacobio Pharmaceuticals Appoints Dr. Andrea Wang-Gillam as Co-CEO to Boost Global Strategy
4M ago
Jacobio Pharmaceuticals Launches Promising Study on JAB-23E73 for KRAS-Altered Tumors
Premium
Company Announcements
Jacobio Pharmaceuticals Launches Promising Study on JAB-23E73 for KRAS-Altered Tumors
4M ago
Jacobio Pharmaceuticals Announces Shareholding Changes and Share Repurchase Updates
PremiumCompany AnnouncementsJacobio Pharmaceuticals Announces Shareholding Changes and Share Repurchase Updates
5M ago
Jacobio Pharmaceuticals Sees Increase in Concert Party Shareholdings
Premium
Company Announcements
Jacobio Pharmaceuticals Sees Increase in Concert Party Shareholdings
6M ago
Jacobio Pharmaceuticals Reports Significant Progress in Oncology Pipeline for H1 2025
Premium
Company Announcements
Jacobio Pharmaceuticals Reports Significant Progress in Oncology Pipeline for H1 2025
6M ago
Jacobio Pharmaceuticals Sees Increased Shareholdings by Concert Parties
PremiumCompany AnnouncementsJacobio Pharmaceuticals Sees Increased Shareholdings by Concert Parties
7M ago
Jacobio Pharmaceuticals Announces Share Repurchase Plan to Boost Shareholder Value
Premium
Company Announcements
Jacobio Pharmaceuticals Announces Share Repurchase Plan to Boost Shareholder Value
8M ago
Jacobio Advances Pan-KRAS Inhibitor JAB-23E73 in Clinical Trials
Premium
Company Announcements
Jacobio Advances Pan-KRAS Inhibitor JAB-23E73 in Clinical Trials
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100